It has been shown that hypophysectomy protects aflatoxin B 1 (AFB 1 ) hepatocarcinogenesis and the prevention of apoptosis is a critical process for tumorigenesis. In this paper, we analyzed the cell death of AFB 1 -induced rat hepatoma Kagura-2 (K2) cells elicited by an estrogen antagonist, tamoxifen (TAM), and transforming growth factor-β1 (TGF-β1) to elucidate the function of endocrine factors in AFB 1 hepatocarcinogenesis. TAM and TGF-β1 induced a typical apoptosis in K2 cells. The apoptotic cell death was efficiently suppressed by glucocorticoids (GCs), but not by other steroid compounds including 17β-estradiol (E 2 ). Cyclo-oxygenase (COX) inhibitors such as aspirin (ASP) and indomethacin (IND) also inhibited the apoptosis, while inhibitory effects of general lipoxygenase (LOX) inhibitors such as nordihydroguaiaretic acid (NDGA) and 5,8,11-eicosatrienoic acid (ETI) were not observed. TAM and TGF-β1 enhanced the release of [ 3 H]arachidonic acid (AA) from pre-labeled K2 cells, which was inhibited by dexamethasone (DEX). Furthermore, cytosolic phospholipase A 2 (cPLA 2 ) activity in K2 cells treated with TAM for 2 h was higher than that in the control. Prostaglandin J 2 (PGJ 2 ) and ∆ 12 -PGJ 2 , AA metabolites formed in the COX pathway, induced K2 cell death. These results suggest that AA metabolites are involved in apoptotic K2 cell death elicited by TAM and TGF-β1, and GCs could act as a tumor promoter in AFB 1 hepatocarcinogenesis through the prevention of apoptosis induced by AA metabolites formed in vivo.
Introduction
It is widely known that aflatoxin B 1 (AFB 1 *) is one of the environmental risk factors for human liver cancer especially in South-east Asia, China and sub-Saharan Africa (1-3). Molecular epidemiological approaches show the high frequency of mutation in codon 249 of the tumor suppressor p53 in these endemic areas (4, 5) . Over-expression of the c-myc gene (6) and point mutation of ras family oncogenes (7, 8) have been reported in AFB 1 -induced rat hepatocellular carcinomas. However, the detailed mechanism of AFB 1 hepatocarcinogenesis is still unknown.
Apoptosis is a genetically encoded cell-death program defined by characteristic morphology and biochemical changes, and is regulated by various signals from both intracellular and extracellular milieus (9) . Apoptosis has a role in many aspects of normal development, maintaining homeostasis and a number of diseases including cancer, autoimmune and neurodegenerative diseases. In carcinogenesis, development of malignancy has been suggested to result not only from abnormal cell proliferation but also from decreased apoptosis (10, 11) . Now, anti-cancer agents have been recognized to kill tumor cells through apoptosis (12) . Thus, the elucidation of apoptotic celldeath mechanism is a critical step for the understanding of carcinogenesis.
It is well established that endocrine factors play an important role in carcinogenesis. Hypophysectomy causes the downregulation of synthesis of steroid hormones and protects against hepatocarcinogenic action of AFB 1 in the rat caused by a change of metabolism of AFB 1 (13) or by a reduced uptake of AFB 1 (14) . Hepatocyte proliferation in vivo and in vitro is stimulated by 17β-estradiol (E 2 ), while tamoxifen (TAM), an estrogen antagonist, inhibits DNA synthesis in hepatocytes (15) . Although TAM has been reported to cause liver cancer in rats and humans (16) , it is widely used in the treatment for human breast cancer (17) . TAM and its derivatives bind to the antiestrogen binding sites (AEBS) that exist in MCF-7 human breast cancer cells (18) and in liver tissue (19) . It has been reported that the antiestrogen action of TAM and its derivatives is mediated by specific AEBS, but not estrogen receptor (ER). However, there is contrasting evidence that AEBS do not directly mediate TAM action (20, 21) . Recently, TAM has been reported to induce apoptosis in ER-negative breast cancer MDA-231 cells through the induction of c-myc gene expression (22) .
It has been shown that TAM induces the secretion of transforming growth factor β1 (TGF-β1) in human breast cancer cells and fibroblast, in which TGF-β1 acts as a growthinhibitor (23) (24) (25) . TGF-β1 belongs to a family of 25 kDa dimeric and multifunctional proteins, including the regulation of cell proliferation, differentiation and morphogenesis (26) . TGF-β1 plays an important role in terminating liver regeneration and induces apoptosis in hepatocytes and hepatoma cells (27) (28) (29) . In colon cancer cells, point mutation of type II TGF-β receptor gene has been reported (30) . Thus, loss of response to TGF-β associates with the tumor development and progression.
Previously, we demonstrated that in Reuber hepatoma H4-II-E cells, metabolically activated AFB 1 interferes with the induction of tyrosine aminotransferase, a liver specific enzyme, through the inhibition of glucocorticoid (GC) receptorhormone complex formation (31) . We also found that dexa- methasone (DEX), a synthetic GC hormone, stimulates the colony formation of AFB 1 -induced rat hepatocellular carcinoma Kagura-2 (K2) cells in semi-solid medium (32) , and prevents apoptotic K2 cell death evoked by sodium 5,6-benzylideneascorbate (SBA), which is a benzylaldehyde derivative and possesses an anticancer activity (33) . Benzylaldehyde has been identified as the main active substance in extracts of the fig fruit (Ficus carica L.) used traditionally in the treatment of cancer (34) . Benzylaldehyde is a reactive compound, which is easily oxidizable and induces strong local irritation (35) . These results suggest the possibility that GCs play a critical role in AFB 1 hepatocarcinogenesis through the suppression of arachidonic acid (AA) cascade, since DEX is well known to inhibit phospholipase A 2 (PLA 2 ) activity (36) .
AA is released from the sn-2 position of the glycerol in phospholipids by PLA 2 to initiate the syntheses of prostaglandins (PGs) and leukotrienes (LTs) by the cyclo-oxygenase (COX) and the lipoxygenase (LOX) pathways, respectively. These AA metabolites regulate cell growth and differentiation (37) (38) (39) (40) (41) , immune response (42) , inflammation (43) and viral replication (44) . In addition to these functions, PGs and LTs 1193 have been reported recently to regulate cell survival and apoptosis (44) (45) (46) (47) .
In this paper, paying attention to AA cascade, we investigated K2 cell death triggered by TAM and TGF-β1 to understand the implication of endocrine factors in AFB 1 hepatocarcinogenesis.
Materials and methods
Reagents TAM, DEX, 17β-estradiol (E 2 ), triamcinolone acetonide (TA), testosterone, progesterone, norhydroguaiaretic acid (NDGA), 5,8,11-eicosatrienoic acid (ETI), propidium iodide (PI) and H-7 were obtained from Sigma (St Louis, MO). Hydrocortisone, cortisone, trans-androsterone, (ϩ)-4-androstene-3,17-dione, cholesterol, indomethacin (IND), aspirin (ASP), PGE 2 , PGF 2 and PGJ 2 were from Wako (Osaka, Japan). ∆ 12 -PGJ 2 was from Funakoshi (Tokyo, Japan). Pregnenolone acetate and human recombinant TGF-β1 were from Aldrich (Milwaukee, DE) and King Zyouzou (Hyougo, Japan), respectively. [5, 6, 8, 9, 11, 12, 14, Cell culture K2 cells were cultivated in collagen-coated culture dishes with Dulbecco's modified Eagle's medium (DMEM) supplemented with 5% fetal calf serum (FCS) as described previously (48) . The cells were maintained at 37°C in a humidified atmosphere of 5% CO 2 in air. Cell viability was determined by exclusion of 0.2% trypan blue. At least 300 cells were counted for each determination using a TATAI hemocytometer.
Analysis of DNA fragmentation K2 cells were seeded at 1ϫ10 5 cells/35-mm dish, cultivated for 24 h and then treated with various concentrations of TAM for 48 h. Both detached and attached cells were simultaneously harvested and centrifuged at 400 g for 5 min. The resulting pellets were rinsed once with Ca 2ϩ /Mg 2ϩ -free phosphatebuffered saline [PBS(-)], suspended in 100 µl PBS(-), and then lysed by the addition of the same volume of 2ϫ lysis buffer [100 mM Tris-HCl (pH 7.8), 2 mM EDTA, 1% (w/v) sodium N-lauroyl sarcocinate]. The lysates were incubated sequentially with 200 µg/ml RNase A for 15 min at 50°C and 200 µg/ml proteinase K for 12 h at 50°C. Electrophoresis of the fragmented DNA (10 µg) was carried out in 2% agarose gel with TBE buffer [89 mM Trisborate (pH 8.0), 89 mM boric acid, 2 mM EDTA] at 100 V for 2 h. The gels were stained with 0.5 µg/ml of ethidium bromide for 30 min and destained with distilled water for 2 h. The photographs of DNA fragments were taken under an UV illuminator. 
Determination of [ 3 H]AA release
The assay of [ 3 H]AA release from pre-labeled K2 cells was carried out according to Lin et al. (49) . K2 cells were seeded at 2ϫ10 4 cells in each well of 24-well plates and cultivated in DMEM containing 1% FCS and 0.25 µCi/ ml of [ 3 H]AA for 24 h. The pre-labeled cells were washed three times with serum-free DMEM to remove the unincorporated [ 3 H]AA and then cultivated with 5ϫ10 -6 M TAM or 5 ng/ml TGF-β1 in DMEM containing 0.5% FCS for 2 h. Radioactivity released into the medium was measured by scintillation counting.
Electron microscopic analysis
The detailed procedure for electron microscopic analysis has been described previously (33, 50) .
Cytosolic PLA 2 (cPLA 2 ) assay Specific assay of cPLA 2 was carried out as reported previously (51) . Briefly, K2 cells treated with or without 5ϫ10 -6 M TAM for 48 h were suspended in homogenizing buffer that consisted of 2 mM dithiothreitol, 10 mM Tris-HCl (pH 7.4), 1 mM EDTA, 1 µg/ml leupeptin, 1 mM phenylmethylsulfonyl fluoride, 150 mM NaCl, 1 µM okadaic acid, 50 mM NaF and 2 mM Na 3 VO 4 , and lysed by sonication. The standard reaction mixture was comprised of 250 µl of 100 mM Tris-HCl (pH 9.0), 2 µM 1-palmitoyl-2-[ 14 C]arachidonoylsn-glycero-3-phosphoethanolamine, 4 mM CaCl 2 , 1 µM okadaic acid and an aliquot of enzyme preparation. The incubation was conducted at 37°C for 30 min. The reaction was stopped by adding 1.25 ml Dole's reagent and free [ 14 C]arachidonate liberated was extracted and counted for radioactivity.
Northern blot analysis of TGF-β1 mRNA
Total RNAs were extracted from rat liver and K2 cells treated with 5ϫ10 -6 M TAM for various times by a LiCl-urea method as described previously (6) . Aliquots of 20 µg total RNA were electrophoresed on 1.2% agarose-6% formaldehyde gel and then blotted onto nitrocellulose filter. Hybridization was performed using 32 P-labeled rat TGF-β1 cDNA probe as described previously (6) . Rat liver mature TGF-β1 cDNA was synthesized by RT-PCR based on mouse TGF-β1 cDNA sequence (5Јprimer: 5Ј-TCCACAGAGAAGAAC-TGCTG-3Ј, 3Јprimer: 5Ј-TCAGCTGCACTTGCAGGAGCGC-3Ј) (52) .
Results

Evidence for apoptotic cell death
We examined the cytotoxic effect of TAM on K2 cells by the trypan blue exclusion method. In the presence of 5ϫ10 -6 M TAM, the fraction of viable cells was decreased in a timedependent manner and was decreased to 60% after 48 h ( Figure 1A ). Cell viability was also dose-dependently depressed by the continuous treatment of 10 -6 -10 -5 M TAM for 48 h, and the maximal depression observed at 1ϫ10 -5 M TAM was estimated to be 37 Ϯ 3% of viability (data not shown). At a higher concentration (Ͼ1ϫ10 -5 M), TAM causes estrogenirreversible cytotoxicity in human breast cancer MCF-7 cells (18) . Therefore, we used 5ϫ10 -6 M TAM for subsequent studies. To examine whether the cell death induced by TAM is apoptosis, we analyzed the DNA fragmentation profile in cells treated with 5ϫ10 -6 M TAM for various times. As shown in Figure 1B , a typical DNA of oligonucleosomal fragments was detectable within 36 h of treatment. This result was further confirmed by a flow cytometric analysis. Non-treated control K2 cells showed a typical pattern of DNA content that reflected G 0 /G 1 , S and G 2 /M phases of the cell cycle ( Figure 1C ). In contrast, the fraction that contained the reduced level of DNA was observed in K2 cells treated with 5ϫ10 -6 M TAM for 48 h, because of the generation of apoptotic bodies, and the fraction of S-phase was reduced from 28.1 to 10.2% when compared with the control (Figure 1D) .
Moreover, time course study with histogram of PI fluorescence versus light scatter, which is established as one of the methods of assessment of cell-cycle-dependent apoptosis based 1196 on the apoptotic cells having less light scatter than those of viable cells (53) , was performed. The degrees of light scatter of some of the G 1 and S-phase cells at 12 and 30 h after the treatment of 5ϫ10 -6 M TAM were decreased, while those of G 2 /M phase cells were not changed (Figure 2 ). This is a typical pattern that results from apoptosis, which is induced by cells that exist in G 1 and S phases as reported previously (53, 54) , and shows that TAM might preferentially induce apoptosis in G 1 and/or S-phase K2 cells.
GC hormones inhibit TAM-induced apoptosis
We have reported that synthetic GCs such as DEX and TA markedly stimulate the growth of K2 cells in semi-solid and serum-free medium (32) and suppress apoptotic K2 cell death induced by SBA (33) . We therefore investigated the effect of various steroid compounds on TAM-induced apoptosis in order to elucidate the apoptotic induction mechanism. K2 cells were treated with 5ϫ10 -6 M TAM in the presence of 1ϫ10 -6 M steroid compounds for 48 h. Authentic and synthetic GCs efficiently suppressed cell death compared with other steroid compounds, including E 2 ( Figure 3A) . On the other hand, the cytotoxic activity of TAM was stimulated in the presence of trans-androsterone or (ϩ)-4-androstene-13,17-dione. The reason for this is presently unclear. DNA fragmentation observed in TAM-treated K2 cells also disappeared in the presence of 1ϫ10 -6 M GCs, while other steroid compounds showed no effects ( Figure 3B ).
COX pathway, but not LOX pathway, is implicated in TAMinduced apoptosis
One of the multiple functions of GCs is the suppression of cytoplasmic PLA 2 (cPLA 2 ) activity (36) . Activation of cPLA 2 permits the release of AA from membrane-bound phospholipids, which is implicated in many signal transduction pathways, including the cell-death signal of TNF (55, 56) . We therefore investigated the effects of COX and LOX inhibitors on TAMinduced apoptosis, to examine whether AA metabolites are implicated in this apoptosis. COX inhibitors, such as ASP and IND, prevented TAM-induced cell death ( Figure 4A ) and DNA fragmentation ( Figure 4C ) in a dose-dependent manner. On the other hand, general LOX inhibitors, such as ETI and NDGA, did not inhibit TAM-induced cell death ( Figure 4B and DNA fragmentation (data not shown), although the concentrations of ETI and NDGA used in this experiment were sufficient to inhibit LOX activity (57) .
Phase-contrast microscopy showed that TAM-elicited dying cells were rounded up and detached from the bottom of the culture dish ( Figure 5B ). In the presence of 2ϫ10 -3 M ASP ( Figure 5C ) or 5ϫ10 -5 M IND (Figure 5D ), the number of dying cells was greatly reduced. In contrast, ETI ( Figure 5E ) and NDGA ( Figure 5F ) did not show any protective effects on TAM-induced apoptosis. These results suggest that the COX pathway plays a crucial role in TAM-induced apoptosis.
Analysis of TGF-β1-induced cell death
TAM has been reported to promote the secretion of TGF-β1 in some cells (23) (24) (25) . Moreover, it is widely known that TGF-β1 is a potent growth inhibitor of hepatocytes and causes apoptosis in hepatocytes and hepatoma cells (27, 28) . To compare the characteristics of TAM-induced apoptosis with 1198 those of the cell death induced by TGF-β1, we first examined the cytotoxic effect of TGF-β1 on K2 cells by the trypan blue exclusion method. K2 cell death was dose-dependently induced by the treatment of 1-10 ng/ml TGF-β1 for 48 h, and the fraction of viable cells was reduced to 70% in the presence of 5 ng/ml TGF-β1 ( Figure 6A) . A substantial amount of DNA was cleaved into typical DNA oligonucleosomal fragments by TGF-β1, which shows that K2 cell death induced by TGF-β1 is apoptosis (data not shown).
To examine whether AA cascade is implicated in TGF-β1-induced apoptosis, we investigated the effect of DEX and ASP. By the addition of Ͼ1ϫ10 -7 M DEX or Ͼ2ϫ10 -3 M ASP, TGF-β1-induced apoptosis was efficiently prevented ( Figure 6A ). In contrast, a LOX inhibitor, NDGA, did not affect this apoptosis ( Figure 6B ). Phase-contrast microscopy showed that the rounded up (Figure 6Cb ) and detached dying cells were non-existent in the presence of 1ϫ10 -6 M DEX Fig. 11 . Northern blot analysis of TGF-β1 gene expression in TAM-treated K2 cells. Aliquots of 20 µg total RNA from K2 cells treated with 5ϫ10 -6 M TAM for various times were electrophoresed on 1.2% agarose-6% formaldehyde gels, transferred onto nitrocellulose filter and hybridized with 32 P-labeled TGF-β1 cDNA. Picture of ethidium bromide stained gel is included to allow comparison of total amount of RNA employed. (Figure 6Cd ). However, K2 cells were morphologically changed to neuron-like cells by the addition of ASP. From these data, it seems likely that AA metabolites are implicated in the cell-death pathway of TGF-β1 as well as TAM.
Stimulation of [ 3 H]AA release by TAM and TGF-β1
To examine whether AA cascade in K2 cells is actually triggered by TAM and TGF-β1, we studied the effect of TAM and TGF-β1 on the release of [ 3 H]AA from pre-labeled K2 cells. Upon exposure K2 cells to 5ϫ10 -6 M TAM or 5 ng/ml TGF-β1 for 2 h, a substantial amount of [ 3 H]AA was released into medium ( Figure 7) . The amounts of released [ 3 H]AA by TAM and TGF-β1 were 2.2-and 2.0-fold higher than that of the non-treated control, respectively. The release of [ 3 H]AA by TAM was suppressed by the addition of 1ϫ10 -6 M DEX. The simultaneous treatment of pre-labeled K2 cells with 1ϫ10 -6 M each of 12-O-tetradecanoyl-phorbol 13-acetate (TPA), a direct activator of protein kinase C (PKC) and A23187, a Ca 2ϩ ionophore, resulted in 11.4-fold increase in [ 3 H]AA release as compared with that of the control. It has been shown in a variety of cells that TPA synergized with A23187 in AA release through the activation of cPLA 2 (49) . K2 cell death was also induced by simultaneous treatment with TPA and A23187 ( Figure 9A ).
To examine whether the stimulation of AA release by TAM is really mediated by cPLA 2 , the enzyme activities in K2 cell lysates prepared after the treatment with or without 5ϫ10 -6 M TAM for 2 h were assayed using 1-palmitoyl-2-[ 14 C]arachidonoyl-sn-glycero-3-phosphoethanolamine as a substrate. Although the basal level of cPLA 2 activity in K2 cells was estimated to be 2.7 pmol [ 14 C]AA released/mg/min and the activity was much lower than those in other cell lines (58) , the liberation of [ 14 C]AA occurred in a dose-dependent manner in up to 50 µg of the lysate (data not shown). When cPLA 2 activity was assayed using 20 µg of the cell lysate, the enzyme activity in TAM-treated K2 cells was 23.8 Ϯ 9.8% higher than that in the vehicle control (Figure 8 ). This increased level of the enzyme activity in TAM-treated K2 cells might be enough to explain the 2.2-fold accumulation of [ 3 H]AA released into the medium as shown in Figure 7 . Thus, it is conceivable that in K2 cells TAM and TGF-β1 stimulate AA release through the activation of cPLA 2 , and that AA metabolites induce K2 cell death. PGJ 2 and ∆ 12 -PGJ 2 , but not PGE 2 and PGF 2α , induce K2 cell death The data described above suggest AA metabolites formed by the COX pathway play a crucial role in the cell-death pathway of TAM and TGF-β1. Moreover, it has been reported that PGs, such as PGE 2 , PGF 2α and ∆ 12 -PGJ 2 , induce apoptosis in murine B lymphocytes (59) , ewe luteal cells (60) and human hepatocarcinoma SK-HEP-1 cells (61), respectively. We therefore examined the cytotoxic effects of PGE 2 , PGF 2α , PGJ 2 Phase-contrast microscopy showed that the dying cells elicited by the treatment with 1ϫ10 -4 M PGJ 2 for 48 h were rounded up and detached from the culture dish ( Figure 10D ). On the other hand, 1ϫ10 -4 M PGE 2 ( Figure 10B ) or PGF 2α ( Figure 10C ) did not show any cytotoxic effects. Electron microscopy studies indicated that significant chromatin condensation, nuclear fragmentation and apoptotic bodies were caused in K2 cells treated with 1ϫ10 -4 M PGJ 2 for 48 h, which suggests that PGJ 2 could induce apoptotic cell death ( Figure 10F ). Similar morphological changes were observed in K2 cells treated with 1ϫ10 -4 M ∆ 12 -PGJ 2 (data not shown). Effect of TAM on TGF-β1 gene expression and death signal transduction TAM has been reported to have a wide variety of pharmacological activities, including induction of TGF-β1 and inhibition of protein kinase C (PKC) (62) . We examined these possibilities in the following experiments. The expression of 2.2 kb TGF-β1 mRNA was hardly detected in K2 cells treated with 5ϫ10 -6 M TAM for various times, although the substantial expression was observed in rat liver (Figure 11 ). This result suggested that TAM-induced apoptosis was not mediated by TGF-β1.
H-7 is a potent inhibitor of PKC and its K i value for PKC is 6ϫ10 -6 M (63). When K2 cells were exposed to Ͻ2.5ϫ10 -5 M H-7 for 48 h, the cytotoxic effect of H-7 was negligible ( Figure 12 ). Even when K2 cells were in the presence of 1ϫ10 -4 M H-7, their viability was estimated to be only 78 Ϯ 3%. This result shows that the cytotoxicity of H-7 for K2 cells is markedly lower than that of TAM, and TAM function as a inhibitor of PKC is not greatly implicated in its apoptotic activity.
Discussion
In these experiments we show that an antiestrogen, TAM, induces apoptosis in AFB 1 -induced rat hepatoma K2 cells that exist in G 1 and/or S-phase, and that this apoptosis can be efficiently prevented by GCs, but not other steroid compounds, including E 2 , possibly because of the inhibition of [ 3 H]AA release. Furthermore, the experiments using COX inhibitors (ASP and IND) and LOX inhibitors (ETI and NDGA) indicate that the COX pathway (in particular, the PGJ 2 and ∆ 12 -PGJ 2 pathways) of AA metabolism may at least in part, play a role in the apoptotic cell death triggered by TAM, as well as TGF-β1, which is an inducer of apoptosis in hepatocytes and hepatoma cells. In addition to the reported functions of endocrine factors, including the effects of AFB 1 metabolism and uptake of AFB 1 (13, 14) , our present data offer the new hypothesis that GCs could act as tumor promoters in AFB 1 hepatocarcinogenesis.
AA metabolites affect a number of signal pathways that modulate cellular adhesion, growth and differentiation. The overexpression of COX-2 in rat intestinal epithelial cells confers upon them a strong resistance to apoptosis, possibly through the induction of Bcl-2 protein expression (46) . It has been also reported that LOX inhibitors and LOX antisense oligonucleotide induce apoptosis in rat carcinosarcoma W256 cells via down-regulation of Bcl-2 protein level (47) . The targeted disruption of LOX and COX genes indicates that AA metabolites play an important role in the immune response (64), pup survival (45) and nephron development (41) .
Conflicting with these data, upon treatment with a relatively high dose of COX and LOX inhibitors, apoptotic K2 cell death was not detected. This may be explained by the fact that in K2 cells, the 14-3-3β gene, a modulator of signal transduction pathways, is overexpressed (65). 14-3-3β protein stimulates Raf-1, kinase which can prevent myeloid cell apoptosis induced by the withdrawal of interleukin (IL)-3 (66, 67) . Accordingly, it seems likely that the function of AA metabolites in K2 cell proliferation and survival may be partially subrogated by 14-3-3β protein.
TAM has been reported to have a wide variety of pharmacological activities including the induction of TGF-β1 (23) (24) (25) . TGF-β1 inhibits growth of epithelial cells through the suppression of c-myc gene expression and phosphorylation of Rb protein (68) . In addition, TGF-β1 induces apoptosis in hepatocytes and hepatomas (27) (28) (29) . These features suggest that TAM elicits apoptosis in K2 cells through the induction of TGF-β1. However, in TAM-treated K2 cells, the expression of TGF-β1 mRNA was not detected. In addition, the proregion of TGF-β1 (latency-associated peptide), which inhibits TGF-β1 activity, did not prevent TAM-induced apoptosis (data not shown). Hence, it seems that the cell-death pathway of TAM is not mediated by TGF-β1.
The activation of AA cascade is essentially required for apoptosis in L929 cells induced by TNF (55) . Additionally TNF and anti-Fas-induced apoptosis are inhibited by Bcl-2 and Bcl-x through the blockage of activation PLA 2 (69) . In ER-negative breast cancer cells it has been reported that TAM causes AA release via oxidative stress and inhibited cell growth through the downregulation of PKC (70) . AA metabolites produced by COX pathway have been shown to elicit apoptosis in various cells, i.e. PGE 2 for murine B cell lymphoma (59), PGF 2α for ewe luteal cells (60) and ∆ 12 -PGJ 2 for human hepatocarcinoma SK-HEP-1 cells (61) . TGF-β1 also stimulates production of PGE 2 in cultured lung fibroblasts and epithelial cells through the induction of COX-1 and PLA 2 gene expressions (71) . These facts offer the possibility that the unnecessary and/or elevated production of AA metabolites causes apoptosis, and our present data suggest that PGJ 2 and ∆ 12 -PGJ 2 formed in the COX pathway are at least in part involved in TAM and TGF-β1-elicited apoptosis in K2 cells. However, the downregulation of PKC may not be implicated in the celldeath pathway of TAM and TGF-β1, since a PKC inhibitor H-7 did not induce K2 cell death. PGJ 2 and its derivatives, ∆ 12 -PGJ 2 and 15-deoxy-∆ 12,14 -PGJ 2 , are formed by the dehydrolyzation of PGD 2 , a major COX product in various cells (72) . Recently, it has been reported that PGD 2 and PGJ 2 series PGs are efficacious activators of the peroxisome proliferator-activated receptor (PPAR) receptors (39, 40) . These reports suggest that in K2 cells, the death signal triggered by PDJ 2 or ∆ 12 -PGJ 2 is transmitted to a death gene via PPAR.
Bayly et al. (73) , however, reported that the non-genotoxic hepatocarcinogen and peroxisome proliferator nafenopin suppresses apoptosis in primary culture of rat hepatocytes and Reuber hepatoma FaO cells evoked by TGF-β1. Therefore, if our hypothesis is correct, it is possible that PPAR could mediate both cell death and survival signals, and some factors that modify the PPAR-mediated signal transduction pathway. It should be noted that there is a remarkable difference among hepatocytes, Reuber FaO and K2 cells. The expression level of c-myc gene in hepatocytes and Reuber cells, known as a minimal deviation hepatoma, is markedly low or negligible, and these cells possess many liver-specific functions such as albumin and tyrosine aminotransferase syntheses (48) . However, K2 cells are overexpressing the c-myc gene and do not maintain liver specific functions (48) . It is well known that c-myc gene plays a critical role in cell differentiation, proliferation and apoptosis (74, 75) . On the basis of these facts, it also seems likely that PPAR-mediated signals are affected by the expression level of c-myc gene and overexpression of c-myc gene is required for PPAR-mediated apoptosis.
In conclusion, it is possible that GCs promote AFB 1 hepatocarcinogenesis through the prevention of apoptosis induced by various cellular defense systems, including TGF-β1 and perhaps TNF, whose actions are mediated at least in part by AA metabolites.
